Study: Doctors differ in how best to care for America's 12 million cancer survivors

July 25, 2011 in Cancer

There are major differences between oncologists and primary care physicians regarding knowledge, attitudes, and practices required to care for American's 12 million cancer survivors. That is the key finding of the first nationally representative survey of doctors that reveals how these differences pose significant barriers to effective communication and coordination of care following initial cancer treatment.

The study, published online today in the , included results of a survey of 1,072 primary cancer physicians (PCP) and 1,130 oncologists randomly sampled from among all U.S. practicing physicians during 2009.

The authors say the findings are of considerable concern, given the rapidly increasing cancer survivor population and looming shortages of both oncology specialists and who will be needed to provide care to this population. Because many individuals stop seeing their oncologist after the first few years following their initial , doctors often assume a large share of providing care to survivors. Optimal cancer survivorship care includes not only surveillance for recurrence or second cancers, but also addressing the long-term and late medical effects of cancer or its treatment, providing psychosocial support, and managing other diseases or conditions.

Several factors may present challenges to ensuring a smooth transition for survivors as they move from initial acute care to post-treatment care, says the study's lead author, Arnold L Potosky, Ph.D., director of health services research at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center.

"What the survey tells us is that many doctors, particularly primary care doctors don't have a high level of confidence in their own knowledge of some aspects of survivorship care, and many oncologists believe that PCPs are not adequately prepared to provide such care. We also see some evidence of knowledge deficits in both physician groups in terms of guideline-based care for survivors," he says.

"Although both oncologists and primary care doctors routinely recommended the use of several laboratory and imaging tests to detect cancer recurrence that are not part of guideline-directed care, more of the primary care physicians recommended these tests than did oncologists," Potosky says.

He says reasons for over-testing may include the practice of defensive medicine, reimbursement incentives for office-based lab testing, or uncertainty regarding best care practices. In some cases, such testing may also be influenced by survivors' requests.

The "Survey of Physicians Attitudes Regarding the Care of " asked both groups of doctors several questions about providing cancer survivorship care including the doctors' confidence in their knowledge about such care, and cancer surveillance practices.

In 2006, a report from the Institute of Medicine (IOM) recommended that patients completing primary treatment for cancer, and their primary care providers, be given a summary of their treatment and a comprehensive plan for follow-up.

Such a plan would inform patients (and their providers) of the long-term effects of cancer and its treatment, identify psychosocial support resources in their communities, and provide guidance on follow-up care, prevention, and health maintenance.

Julia Rowland, Ph.D., director of the Office of Cancer Survivorship at the National Cancer Institute and a co-author, says this study suggests several key insights regarding the implementation of the IOM's recommendations.

"More training and education on cancer survivorship is critical for the primary care physician and the oncologist," she says. "This might include identification of who may be best equipped to provide different aspects of care. Use of a survivorship care plan has the potential to serve as a valuable tool for helping to improve communication about as well as coordination of care between specialists and primary for survivors who are post-treatment."

The authors suggest that a survivor, upon finishing treatment, meet with the treating oncologist to summarize the care received and outline appropriate follow-up care based on personal treatment history. They add that patients should find out what aspects of care to expect from the oncologist and the primary care physician respectively.

More information: http://www.cancer. … nt+Summaries

Provided by Georgetown University Medical Center search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Nonsmoking lung cancer survivor encourages others to consider risk

Carol Seibert had an upper respiratory infection she just couldn’t seem to shake. The timing of her illness was awful, as she had just returned from a trip to Florida for her youngest son’s surgery and was preparing ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...

Cancer created 13 hours ago | popularity not rated yet | comments 0

Childhood cancer scars survivors later in life

Scars left behind by childhood cancer treatments are more than skin-deep. The increased risk of disfigurement and persistent hair loss caused by childhood cancer and treatment are associated with emotional distress and reduced ...

Cancer created 15 hours ago | popularity not rated yet | comments 0

Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

Cancer created 15 hours ago | popularity 5 / 5 (4) | comments 1 | with audio podcast

Marked for destruction: Newly developed compound triggers cancer cell death

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic ...

Cancer created 19 hours ago | popularity 5 / 5 (1) | comments 0


New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The in ...

Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances

(Medical Xpress) -- The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by ...

World 'no tobacco day' puts spotlight on dangers of smoking

It’s not just smokers who are at-risk when it comes to tobacco smoke exposure—and the health concerns of smoking cigarettes are not limited to the most known consequence: lung cancer. 

Like curry? New biological role identified for compound used in ancient medicine

Scientists have just identified a new reason why some curry dishes, made with spices humans have used for thousands of years, might be good for you.

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...